100 related articles for article (PubMed ID: 12955427)
1. A comparison of 1-month and 6-month clopidogrel therapy on clinical and angiographic outcome after stent implantation.
Pekdemir H; Cin VG; Camsari A; Cicek D; Akkus MN; Doven O; Parmaksiz T
Heart Vessels; 2003 Jul; 18(3):123-9. PubMed ID: 12955427
[TBL] [Abstract][Full Text] [Related]
2. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents.
Calver AL; Blows LJ; Harmer S; Dawkins KD; Gray HH; Morgan JH; Simpson IA
Am Heart J; 2000 Sep; 140(3):483-91. PubMed ID: 10966552
[TBL] [Abstract][Full Text] [Related]
3. A paclitaxel-eluting stent for the prevention of coronary restenosis.
Park SJ; Shim WH; Ho DS; Raizner AE; Park SW; Hong MK; Lee CW; Choi D; Jang Y; Lam R; Weissman NJ; Mintz GS
N Engl J Med; 2003 Apr; 348(16):1537-45. PubMed ID: 12700373
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation (from the DECLARE-Long trial).
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ;
Am J Cardiol; 2007 Oct; 100(7):1103-8. PubMed ID: 17884371
[TBL] [Abstract][Full Text] [Related]
5. Effects of triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol) on platelet aggregation and P-selectin expression in patients undergoing coronary artery stent implantation.
Lee BK; Lee SW; Park SW; Lee SW; Park DW; Kim YH; Lee CW; Hong MK; Kim JJ; Jang S; Chi HS; Park SJ
Am J Cardiol; 2007 Aug; 100(4):610-4. PubMed ID: 17697815
[TBL] [Abstract][Full Text] [Related]
6. Long-term clinical outcome of patients treated with beta-brachytherapy in routine clinical practice.
Nikas DN; Kalef-Ezra J; Katsouras CS; Tsekeris P; Bozios G; Pappas C; Naka KK; Kotsia A; Papamichael N; Sideris DA; Michalis LK
Int J Cardiol; 2007 Feb; 115(2):183-9. PubMed ID: 16890309
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of abciximab for prevention of in-stent restenosis in diabetic patients after coronary stenting: results of the ASIAD (Abciximab in Stenting Inhibits restenosis Among Diabetics) Trial.
Chen WH; Kaul U; Leung SK; Lau YK; Tan HC; Leung AW; Lee MK; Li SK; Ng W; Lee PY; Lam KF; Tse HF; Lau CP
J Invasive Cardiol; 2005 Oct; 17(10):534-8. PubMed ID: 16204748
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
[TBL] [Abstract][Full Text] [Related]
9. Twelve versus six months of clopidogrel to reduce major cardiac events in patients undergoing gamma-radiation therapy for in-stent restenosis: Washington Radiation for In-Stent restenosis Trial (WRIST) 12 versus WRIST PLUS.
Waksman R; Ajani AE; Pinnow E; Cheneau E; Leborgne L; Dieble R; Bui AB; Satler LF; Pichard AD; Kent KK; Lindsay J
Circulation; 2002 Aug; 106(7):776-8. PubMed ID: 12176945
[TBL] [Abstract][Full Text] [Related]
10. Treatment of multilesion coronary artery disease with simultaneous drug-eluting and bare-metal stent implantation: clinical follow up and angiographic mid-term results.
Mirabella F; Francaviglia B; Capodanno D; Di Salvo ME; Galassi AR; Ussia GP; Capranzano P; Tamburino C
J Invasive Cardiol; 2009 Apr; 21(4):145-50. PubMed ID: 19342750
[TBL] [Abstract][Full Text] [Related]
11. [Immediate and long-term clinical and angiographic results of the Wiktor stent in the treatment of chronic coronary occlusions].
Anzuini A; Rosanio S; Legrand V; Tocchi M; Coppi R; Marazzi G; Vicedomini G; Pagnotta P; Montorfano M; Bonnier H; Sheiban I; Kulbertus HE; Chierchia SL
G Ital Cardiol; 1997 Sep; 27(9):881-91. PubMed ID: 9378193
[TBL] [Abstract][Full Text] [Related]
12. Drug-eluting stenting followed by cilostazol treatment reduces late restenosis in patients with diabetes mellitus the DECLARE-DIABETES Trial (A Randomized Comparison of Triple Antiplatelet Therapy with Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Diabetic Patients).
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Hong MK; Kim HS; Ko JK; Park JH; Lee JH; Choi SW; Seong IW; Cho YH; Lee NH; Kim JH; Chun KJ; Park SJ
J Am Coll Cardiol; 2008 Mar; 51(12):1181-7. PubMed ID: 18355656
[TBL] [Abstract][Full Text] [Related]
13. Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
Kastrati A; Schühlen H; Hausleiter J; Walter H; Zitzmann-Roth E; Hadamitzky M; Elezi S; Ulm K; Dirschinger J; Neumann FJ; Schömig A
Circulation; 1997 Jul; 96(2):462-7. PubMed ID: 9244213
[TBL] [Abstract][Full Text] [Related]
14. Comparison of dual versus triple antiplatelet therapy after drug-eluting stent according to stent length (from the pooled analysis of DECLARE trials).
Lee SW; Lee JY; Ahn JM; Park DW; Han S; Park YK; Lee WS; Jang JY; Kwon CH; Park GM; Cho YR; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Am J Cardiol; 2013 Dec; 112(11):1738-44. PubMed ID: 24063835
[TBL] [Abstract][Full Text] [Related]
15. Increased long term rates of stent thrombosis and mortality in patients given clopidogrel as compared to ticlopidine following coronary stent implantation.
Wolak A; Amit G; Cafri C; Gilutz H; Ilia R; Zahger D
Int J Cardiol; 2005 Sep; 103(3):293-7. PubMed ID: 16098392
[TBL] [Abstract][Full Text] [Related]
16. Prolonged antiplatelet therapy to prevent late thrombosis after intracoronary gamma-radiation in patients with in-stent restenosis: Washington Radiation for In-Stent Restenosis Trial plus 6 months of clopidogrel (WRIST PLUS).
Waksman R; Ajani AE; White RL; Pinnow E; Dieble R; Bui AB; Taaffe M; Gruberg L; Mintz GS; Satler LF; Pichard AD; Kent KK; Lindsay J
Circulation; 2001 May; 103(19):2332-5. PubMed ID: 11352879
[TBL] [Abstract][Full Text] [Related]
17. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
[TBL] [Abstract][Full Text] [Related]
18. Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
Schömig A; Neumann FJ; Walter H; Schühlen H; Hadamitzky M; Zitzmann-Roth EM; Dirschinger J; Hausleiter J; Blasini R; Schmitt C; Alt E; Kastrati A
J Am Coll Cardiol; 1997 Jan; 29(1):28-34. PubMed ID: 8996291
[TBL] [Abstract][Full Text] [Related]
19. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Sick PB; Brosteanu O; Ulrich M; Thiele H; Niebauer J; Busch I; Schuler G
Am Heart J; 2005 Apr; 149(4):681-8. PubMed ID: 15990753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
